Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR7 | Q9NYK1 | 7/20 | 0.47 |
| ▸ | TLR8 | Q9NR97 | 6/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | PIM1 | P11309 | 1/20 | 0.35 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.35 |
| ▸ | HRH1 | P35367 | 3/20 | 0.35 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.34 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1233387 | 0.85 | TDP1 (0.40) | TLR7TLR8MAPTMEN1KMT2A | |
| SCHEMBL7252628 | 0.84 | EPHX2 (0.43) | MAPTMEN1KMT2A | |
| SCHEMBL12888448 | 0.83 | HPGD (0.42) | TLR7TLR8MAPTHSP90AB1PDE10A | |
| SCHEMBL27666505 | 0.82 | TLR7 (0.44) | TLR7TLR8 | |
| SCHEMBL6929530 | 0.82 | STING1 (0.43) | TLR7TLR8MEN1KMT2A | |
| SCHEMBL4312799 | 0.81 | SMN1; SMN2 (0.40) | TLR7TLR8MAPTPDE10A | |
| SCHEMBL4316388 | 0.80 | TLR7 (0.40) | TLR7TLR8MAPTPDE10A | |
| SCHEMBL4151944 | 0.80 | GAA (0.37) | TLR7TLR8MEN1KMT2APDE10A | |
| SCHEMBL6927938 | 0.79 | HDAC3 (0.34) | MAPTMEN1KMT2AHSP90AA1HSP90AB1 | |
| SCHEMBL3176214 | 0.79 | TLR7 (0.49) | TLR7MAPTMEN1KMT2APDE10A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030212093-A1 | Viricides, antitumor agents | 3M INNOVATIVE PROPERTIES COMPANY | 2003-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030212093-A1 | Viricides, antitumor agents | IFNG, IFNAR1, MAVS | TLR7 116/4885TLR8 292/4885MAPT 4481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.